MetaCap

Who Owns Axsome Therapeutics Stock?

NASDAQ: AXSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

129.36-6.32 (-4.66%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
77.71%
Institutional holders
622
  • Institutions 77.7%
  • Insiders 15.0%
  • Public and other 7.3%

Who owns Axsome Therapeutics stock?

Institutional investors own about 77.7% of Axsome Therapeutics's shares, spread across 622 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 15.02% of AXSM.

The largest institutional holders are Blackrock Inc. (6.56%), Vanguard Capital Management LLC (3.82%) and Vanguard Portfolio Management LLC (3.75%). Together, the top 10 institutions control 29.3% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their AXSM positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of AXSM

Axsome Therapeutics top institutional holders
InstitutionShares% HeldChange
Blackrock Inc.3.45M6.56%+11.2%
Vanguard Capital Management LLC2.01M3.82%+2.1%
Vanguard Portfolio Management LLC1.97M3.75%-0.6%
Invesco Ltd.1.93M3.67%+15.5%
FMR, LLC1.44M2.75%-6.2%
Two Sigma Investments, LP1.11M2.11%+65.9%
Geode Capital Management, LLC1.01M1.92%+4.5%
UBS Group AG849.77K1.62%+459.4%
State Street Corporation823.33K1.57%+4.8%
Deep Track Capital, Lp800.00K1.52%+14.3%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of AXSM

Axsome Therapeutics top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.39M2.64%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.00M1.91%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund578.23K1.10%
AIM Counselor Series TRT -Invesco Discovery Fd.535.27K1.02%
Vanguard Explorer Fund531.00K1.01%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund495.76K0.94%
First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd.387.24K0.74%
iShares Trust-iShares Biotechnology ETF343.59K0.65%
Franklin Custodian Funds-FRANKLIN DYNATECH FUND300.00K0.57%
Fidelity Select Portfolios-Select Biotechnology Portfolio278.08K0.53%

Frequently asked questions

Who is the largest shareholder of Axsome Therapeutics?

Blackrock Inc. is the largest institutional shareholder of AXSM, owning 6.56% of shares outstanding (3.45M shares) as of its latest 13F filing.

What percentage of Axsome Therapeutics is owned by institutions?

Institutions own about 77.7% of AXSM shares and 91.4% of the public float.

How much of Axsome Therapeutics do insiders own?

Insiders, such as officers and directors, own about 15.02% of AXSM shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related